contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


thor-medical-asa-notice-of-annual-general-meeting-on-23-april-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Thor Medical är en producent och leverantör av alfapartikelemitterare för cancerbehandling. Radionuklidterapi (RNT) eller radioligandterapi (RLT) som använder alfapartikelemitterare är en lovande teknik för cancerbehandling. Huvudfokus för bolaget är att förfina produktionstekniken, säkra kundbasen och nödvändiga myndighetsgodkännanden för industrialisering. Thor Medical har sitt huvudkontor i Oslo.

Thor Medical

1.4.2026 08:00:00 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state Notice is given that the Annual General Meeting of Thor...

<pre>1.4.2026 08:00:00 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state Notice is given that the Annual General Meeting of Thor Medical ASA will be held on 23 April 2026, at 14:00 hours CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The full notice and appendices are attached. The notice and the documents to which it refers are also available on www.thormedical.com - https://www.thormedical.com. DISCLOSURE REGULATION This information is required to be disclosed under Section 5-12 of the Securities Trading Act. For further information please contact: Mathias Nilsen Reierth Head of Communications and Corporate Affairs Tel: +47 988 05 724 mathias.reierth@thormedical.com ABOUT THOR MEDICAL ASA Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.com - https://www.thormedical.com ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18852092/6952/Download%20announce ment%20as%20PDF.pdf Thor Medical - Proposed resolutions for the AGM 2026 English.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18852092/6946/Thor%20Medical%20-% 20Proposed%20resolutions%20for%20the%20AGM%202026%20English.pdf Thor Medical - Proposed resolutions for the AGM 2026 Norsk.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18852092/6947/Thor%20Medical%20-% 20Proposed%20resolutions%20for%20the%20AGM%202026%20Norsk.pdf Thor Medical - Notice of AGM 2026 English.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18852092/6950/Thor%20Medical%20-% 20Notice%20of%20AGM%202026%20English.pdf Thor Medical - Notice of AGM 2026 Norsk.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18852092/6951/Thor%20Medical%20-% 20Notice%20of%20AGM%202026%20Norsk.pdf </pre>